Navigation Links
A revolution in the monitoring of unborn babies

New technology, the size of a mobile phone, which could save the life of an unborn child, has been developed by scientists from The University of Nottingham. The device monitors the baby’s heart for signs of potential danger. It is small and easy to use so that mother’s-to-be can keep a regular check on their baby’s heart beat without having to go into hospital and be attached to a machine. No other technology allows them to do this.

It took 15 years of pioneering work and enterprise, with funding from Action Medical Research and Venture Capital, to develop the fetal heart monitor. Researchers believe the device has the potential to benefit 70,000 at risk babies a year in the UK alone.

Statistics show that as many as 10 babies a day are stillborn in the UK and 10 per cent of all pregnancies each year are high risk. The monitor lets doctors read signals produced naturally by the unborn baby’s heart. They can then intervene if necessary and potentially save their lives.

The fetal monitor is the result of years of collaborative work between engineers and doctors at the University. The original research was carried out by Dr John Crowe and Dr Barrie Hayes-Gill in the School of Electrical and Electronic Engineering (EEE) and Professor David James and Dr Margaret Ramsay in the School of Human Development. In 2005 the technology was spun out to create Monica Healthcare Ltd. Led by both Dr Hayes-Gill and two ex PhD researchers from EEE, Dr Carl Barratt and Jean Francois Pieri, the company has gone on to develop the monitor even further.

This highly sensitive device, which is able to detect 0.00000001 volts, has now been reduced to the size of a mobile phone. It can compute real time fetal readings and the resulting data can be transmitted by wireless technology to the nearest PC or hand held computer. The device has now passed all EU regulatory safety standards and is currently undergoing clinical trials.

Dr Barrie Hayes-Gi ll expects the device to go on sale in October this year. “To date we have successfully completed over 33 per cent of the clinical trial. We expect to complete clinical trials in July 2007. This represents a tremendous achievement to turn a research device into a medically approved product in only two years ?an experience which will place us in good stead for future medical products that we have on our horizon.?

Currently hospital based ultrasound is used to record babies?heart rates during pregnancy. While this technique has proven benefits, it needs to be administered by trained professionals and it is not suitable for routine, continuous, long-term monitoring. Dr Barrie Hayes-Gill and Dr John Crowe at The University of Nottingham recognised the need for a new technology that would fill these gaps.

One of the biggest obstacles in developing the fetal monitor was separating the baby’s heart beat from the mother’s signal. The team has successfully created a state-of-the-art device which can gauge both heart rates as well as fetal position. This unique home monitoring device could lead to a new approach in the management of pregnancy.

Dr Margaret Ramsay says it will play a key role in monitoring high-risk pregnancies. “For all these fetuses, the more we can monitor them, the greater the chance of us detecting that they are running into difficulties before it is too late to help them. This may involve urgent delivery of the fetus.?

The device will be especially helpful in monitoring fetuses whose mothers have medical conditions like diabetes, autoimmune conditions such as systemic lupus erythematosus and Sjogren’s syndrome and obstetric cholestasis. It will also be useful in monitoring fetuses identified as growing poorly or where it is suspected that the placenta is unhealthy and hence the fetus may become compromised due to lack of oxygen.?

In England during 2004 and 2005 17 per cent of inpatient cases for women in N HS hospitals were due to complications of pregnancy or childbirth. By helping to detect potential problems with unborn babies early and monitoring expectant mothers in their own homes it is hoped the device could relieve the pressure on in-patient stays and reduce hospital costs. As well as spotting potential complications the new monitor can be used to provide reassurance and mother-baby bonding.

Source:University of Nottingham

Related biology news :

1. NHGRI expands effort to revolutionize sequencing technologies
2. Fruit fly research set to revolutionize study of birth defects
3. Software might revolutionize glucose monitoring in critically ill patients
4. Nanopore method could revolutionize genome sequencing
5. Patients to benefit from novel technology revolutionizing high-speed molecular imaging
6. A new study of living cells could revolutionize the way we test drugs
7. Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
8. MERIS monitoring tracks planetary photosynthesis levels
9. Carnegie Mellon cyLab researchers work to develop new red tide monitoring
10. Technology for monitoring fetal oxygen during labor offers no apparent benefit
11. Cardiologists living chip changes science of disease monitoring

Post Your Comments:

(Date:11/26/2015)... Research and Markets ( ) has announced the ... and Patent Infringement Risk Analysis" report to their ... Fingerprint sensors using capacitive technology represent a fast ... Idex forecasts an increase of 360% of the number ... the fingerprint sensor market between 2014 and 2017 (source ...
(Date:11/20/2015)... -- NXTD ) ("NXT-ID" or the "Company"), ... commerce market and creator of the Wocket® smart wallet, ... interviewed on The RedChip Money Report television ... Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, and ... ) ("NXT-ID" or the "Company"), a biometric authentication company ...
(Date:11/19/2015)...  Based on its in-depth analysis of the biometric ... the 2015 Global Frost & Sullivan Award for Product ... this award to the company that has developed the ... the market it serves. The award recognizes the extent ... customer base demands, the overall impact it has in ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
(Date:11/24/2015)... ... 2015 , ... In harsh industrial processes, the safety of ... can represent a weak spot where leaking process media is a possible hazard. ... , which are designed to tolerate extreme process conditions. They combine rugged design ...
(Date:11/24/2015)... Nov. 24, 2015 HemoShear Therapeutics, LLC, ... drugs for metabolic disorders, announced today the appointment ... Board of Directors (BOD). Mr. Watkins is the ... Genome Sciences (HGS), and also served as the ... Jim Powers , Chairman and CEO of HemoShear ...
Breaking Biology Technology: